EP0832126A4 - Htnad29 recepteurs de proteines g - Google Patents

Htnad29 recepteurs de proteines g

Info

Publication number
EP0832126A4
EP0832126A4 EP95923763A EP95923763A EP0832126A4 EP 0832126 A4 EP0832126 A4 EP 0832126A4 EP 95923763 A EP95923763 A EP 95923763A EP 95923763 A EP95923763 A EP 95923763A EP 0832126 A4 EP0832126 A4 EP 0832126A4
Authority
EP
European Patent Office
Prior art keywords
htnad29
receptors
protein
htnad29 protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95923763A
Other languages
German (de)
English (en)
Other versions
EP0832126A1 (fr
Inventor
Yi Li
Rebecca A Fuldner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0832126A1 publication Critical patent/EP0832126A1/fr
Publication of EP0832126A4 publication Critical patent/EP0832126A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Plant Pathology (AREA)
EP95923763A 1995-06-06 1995-06-06 Htnad29 recepteurs de proteines g Withdrawn EP0832126A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007288 WO1996039442A1 (fr) 1995-06-06 1995-06-06 Htnad29 recepteurs de proteines g

Publications (2)

Publication Number Publication Date
EP0832126A1 EP0832126A1 (fr) 1998-04-01
EP0832126A4 true EP0832126A4 (fr) 2000-01-12

Family

ID=22249278

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95923763A Withdrawn EP0832126A4 (fr) 1995-06-06 1995-06-06 Htnad29 recepteurs de proteines g

Country Status (7)

Country Link
EP (1) EP0832126A4 (fr)
JP (1) JPH11506341A (fr)
KR (1) KR19990022531A (fr)
CN (1) CN1147505C (fr)
AU (1) AU714642B2 (fr)
CA (1) CA2221706A1 (fr)
WO (1) WO1996039442A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221627B1 (en) * 1997-02-24 2001-04-24 Smithkline Beecham Corporation cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
EP2264068A1 (fr) * 1998-10-13 2010-12-22 Arena Pharmaceuticals, Inc. Récepteurs non-endogènes de la protéine G humaine ayant une activité constitutive
JP2003506042A (ja) 1999-08-03 2003-02-18 ミレニアム ファーマシューティカルズ インク． セクレチン様ファミリーの新規ｇｐｃｒ様分子１５５７１及びその使用
US6919176B2 (en) 2001-05-07 2005-07-19 Amgen Inc. Polypeptides and nucleic acids associated with cancer
AU2003206749A1 (en) * 2002-02-01 2003-09-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with the gpr65 receptor
BRPI0411668A (pt) 2003-06-20 2006-08-08 Novartis Ag receptores acoplados à proteìna g sensìveis a próton e seqüências de dna dos mesmos
WO2008101354A1 (fr) * 2007-02-22 2008-08-28 Merck Frosst Canada Ltd Gpr65 utilisé comme cible thérapeutique dans une inflammation allergique des voies respiratoires

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001810A1 (fr) * 1990-07-19 1992-02-06 Lerner Michael R Procedes d'identification de composes agissant comme agonistes ou antagonistes sur des proteines impliquees dans la transduction de signaux biologiques
WO1993007294A1 (fr) * 1991-10-01 1993-04-15 The United States Of America, Represented By The Secretary, Department Of Health And Human Service Procede d'identification de ligands et d'antagonistes de ligands
WO1993012134A1 (fr) * 1991-12-11 1993-06-24 President And Fellows Of Harvard College Diagnostic de maladies degeneratives retiniennes hereditaires
WO1994005695A1 (fr) * 1992-09-10 1994-03-17 New York University Polypeptides de recepteurs proteiques couples a la proteine g, leurs compositions et leurs procedes d'utilisation
WO1996027603A1 (fr) * 1995-03-03 1996-09-12 Millennium Pharmaceuticals, Inc. Compositions et procedes de traitement et de diagnostic de troubles immunitaires

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001810A1 (fr) * 1990-07-19 1992-02-06 Lerner Michael R Procedes d'identification de composes agissant comme agonistes ou antagonistes sur des proteines impliquees dans la transduction de signaux biologiques
WO1993007294A1 (fr) * 1991-10-01 1993-04-15 The United States Of America, Represented By The Secretary, Department Of Health And Human Service Procede d'identification de ligands et d'antagonistes de ligands
WO1993012134A1 (fr) * 1991-12-11 1993-06-24 President And Fellows Of Harvard College Diagnostic de maladies degeneratives retiniennes hereditaires
WO1994005695A1 (fr) * 1992-09-10 1994-03-17 New York University Polypeptides de recepteurs proteiques couples a la proteine g, leurs compositions et leurs procedes d'utilisation
WO1996027603A1 (fr) * 1995-03-03 1996-09-12 Millennium Pharmaceuticals, Inc. Compositions et procedes de traitement et de diagnostic de troubles immunitaires

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002121362, Database accession no. T87010 *
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002121363, Database accession no. T86932 *
DATABASE SWISSPROT 1 January 1900 (1900-01-01), XP002121817, Database accession no. P32250 *
LEE N.H. AND KERLAVAGE A.R.: "Molecular biology of G-protein-coupled receptors", DRUG NEWS AND PERSPECTIVES, vol. 6, no. 7, 1 September 1993 (1993-09-01), pages 488 - 497, XP000677175, ISSN: 0214-0934 *
OLIVEIRA L. ET AL.: "A common motif in G-protein-coupled seven transmembrane helix receptors", JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, vol. 7, no. 6, 1 December 1993 (1993-12-01), pages 649 - 658, XP002050853, ISSN: 0920-654X *
See also references of WO9639442A1 *

Also Published As

Publication number Publication date
KR19990022531A (ko) 1999-03-25
WO1996039442A1 (fr) 1996-12-12
CN1147505C (zh) 2004-04-28
CA2221706A1 (fr) 1996-12-12
AU2820495A (en) 1996-12-24
AU714642B2 (en) 2000-01-06
CN1193980A (zh) 1998-09-23
EP0832126A1 (fr) 1998-04-01
JPH11506341A (ja) 1999-06-08

Similar Documents

Publication Publication Date Title
EP0711303A4 (fr) Biotinylation de proteines
FI973162A0 (fi) Liikalihavuutta vastustavia proteiineja
EP1040117A4 (fr) 110 proteines secretees humaines
EP0868178A4 (fr) Antagonistes de la gonadoliberine
NO973404D0 (no) Humant interleukin-1-reseptor aksessorisk protein
DE59603707D1 (de) Pleuelstange
BR9606876A (pt) Aplicador de tampão
EP0706657A4 (fr) Interactions de proteines inhibitrices
DE69735926D1 (de) Interleukin-18 Rezeptorproteine
EP0817800A4 (fr) Recepteurs couples par une proteine-g humaine
EP0832125A4 (fr) Recepteur hgber32 de proteine g humaine
DK0779035T3 (da) Modificeret valleprotein
BR9610239A (pt) Proteínas de fusão-alérgeno-xcd32
BR9609671A (pt) Amino uracilas substituídas
BR9606951A (pt) Proteinas matantes
EP0832126A4 (fr) Htnad29 recepteurs de proteines g
EP0873409A4 (fr) Proteines du rhinovirus equin 1
NO980375D0 (no) Humant MP52 Arg protein
BR9606756A (pt) Peptídeo
NO981052D0 (no) Peptidderivater
EP0804556A4 (fr) Enzyme modificatrice de proteines
NO981051D0 (no) Peptidderivater
DE69615850D1 (de) G-protein-gekoppelter rezeptor hnfd578
EP0871668A4 (fr) Hibef51, recepteur de proteines g humaines
EP1004665A4 (fr) Proteines du type recepteurs accepteurs

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19971230

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19991129

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020416

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060607